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MicroRNAs have been shown to be critical for
a number of aspects of immune system regulation
and function. Here, we have examined the role of mi-
croRNAs in terminal B cell differentiation by
analyzing Cd19-Creki/+ Dicer1fl/fl mice. We found
that in the absence of Dicer, the transitional and
marginal zone (MZ) B cell compartments were over-
represented and follicular (FO) B cell generation
was impaired. microRNA analysis revealed that
miR185, a microRNA overexpressed in FO cells,
dampened B cell receptor (BCR) signaling through
Bruton tyrosine kinase downregulation. Dicer-defi-
cient B cells had a skewed BCR repertoire with
hallmarks of autoreactivity, which correlated with
high titers of autoreactive antibodies in serum and
autoimmune features in females. Together, our
results reveal a crucial role for microRNAs in late B
cell differentiation and in the establishment of B cell
tolerance.
INTRODUCTION
Primary antibody diversification is generated during B cell differ-
entiation in the bone marrow through somatic DNA rearrange-
ment of immunoglobulin (Ig) genes by V(D)J recombination
(Bassing et al., 2002). Because of its stochastic nature, antibody
diversification can give rise to B cell antigen receptors (BCRs)
that recognize the body’s self components and potentially lead
to autoimmunity. This pathological outcome is usually prevented
by tolerance mechanisms that are governed by signals delivered
by the BCR (Gu et al., 1991; Hartley et al., 1991; Meffre et al.,
2000; Meffre and Wardemann, 2008; Shlomchik, 2008; Warde-
mann and Nussenzweig, 2007). Two main checkpoints ensure
B cell tolerance: one is established in the bone marrow in early
immature B cells that have completed V(D)J recombination of
heavy and light Ig genes (Goodnow et al., 1988; Nemazee and
Bu¨rki, 1989; Wardemann et al., 2003), and the second takes
place in peripheral B cells in transit to their final maturation
(Wardemann et al., 2003). At this late maturation stage, transi-
tional B cells can give rise to two functionally distinct peripheral
populations: follicular (FO) or marginal zone (MZ) B cells (Allman
and Pillai, 2008; Carsetti et al., 2004). FO versusMZ fate decision
is functionally coupled to BCR signaling (Carsetti et al., 2004;IPillai and Cariappa, 2009), and it has been suggested that B cells
bearing BCRs with autoreactive specificities are preferentially
driven into a MZ fate (Li et al., 2002; Martin and Kearney,
2000). However, the molecular mechanisms that regulate this
transition and its link to B cell tolerance establishment remain
poorly understood.
MicroRNAs are small RNA (21–22 nucleotides long) posttran-
scriptional regulators of gene expression, which have been
unveiled to be critical for numerous aspects of the regulation
and maintenance of the mammalian immune system (Martinez
and Busslinger, 2007; Xiao and Rajewsky, 2009). Mature micro-
RNAs are generated through the sequential cleavage of longer
RNA precursors by Drosha and Dicer (gene name Dicer1) RNA
endonucleases (Kim et al., 2009). Early Dicer ablation in the B
cell lineage results in an almost complete block of B cell differen-
tiation at the pro-B cell stage; such a block is due to an aberrant
regulation of apoptosis in the bone marrow (Koralov et al., 2008).
These results highlight the essential role of microRNAs in B cell
generation in the bone marrow; however, the severity of the
phenotype precluded the analysis of terminal B cell differentia-
tion and selection.
Here, we have addressed the role of microRNAs at late B cell
differentiation stages in Cd19-Creki/+Dicer1fl/fl mice, which
allowed B cell-specific Dicer deletion. Mature B cells were
generated in Cd19-Creki/+ Dicer1fl/fl mice, in which transitional
and MZ B cells were overrepresented and the generation of FO
B cells was impaired. MicroRNA analysis revealed that
miR185, a microRNA differentially expressed in FO versus MZ
B cells, promoted downregulation of the BCR signaling effector
Bruton tyrosine kinase (Btk) in activated B cells. Importantly,
Dicer-deficient B cells produced high titers of autoreactive anti-
bodies, which correlated with the presence of autoimmune
features in aged female animals. Therefore, our results provide
evidence for a role of microRNAs in terminal B cell differentiation
and in the establishment of B cell tolerance.RESULTS
Mature B Cells Are Generated in Cd19-Creki/+ Dicer1fl/fl
Mice
To address the function of microRNAs at late stages of B cell
development, we generated B cell-specific Dicer-deficient
mice by breeding Cd19-Creki/+ (Rickert et al., 1997) to Dicer1fl/fl
mice (Harfe et al., 2005). Cd19-Cre-mediated deletion takes
place gradually during bone marrow differentiation (Hobeika
et al., 2006; Schmidt-Supprian and Rajewsky, 2007) in contrast
to Dicer ablation by Cd79a-Cre (also known as mb1-Cre)mmunity 33, 713–722, November 24, 2010 ª2010 Elsevier Inc. 713
Figure 1. Total Peripheral B Cells Are Reduced and MZ and T Subsets Are Overrepresented in the Absence of Dicer
Phenotypic analysis of bonemarrow (A andB), spleen (C, E, and F) and lymph nodes (D) fromCd19-Creki/+Dicer1fl/+ andCd19-Creki/+Dicer1fl/fl mice. Cell suspen-
sions were stained with the indicated antibodies and analyzed by flow cytometry. Representative FACS analyses are shown on the left for total cells (A, C, and D),
B220+-gated cells (B and E), or B220+CD23bright-gated cells (F). Graphs on the right show the frequency of the indicated subsets in individual mice analyzed as
follows: (A) B220+ bone marrow B cells (n = 18–21, p = 0.01); (B) IgM+IgD immature B (n = 8–11, p = 0.62) and IgD+ recirculating B cells (n = 8–11, p < 0.01); (C)
B220+ spleen B cells (n = 31-33, p < 0.01); (D) B220+ lymph node cells (n = 11, p < 0.01); (E) CD21brightCD23+ marginal zone (MZ) (n = 9–11, p < 0.01); and (F)
CD21+CD23brightCD93 follicular (FO) (n = 9–11, p < 0.01), and CD21+CD23brightCD93+ transitional (T) cells (n = 9–11, p < 0.01) within total spleen B cells. Circles
represent Cd19-Creki/+ Dicer1fl/+ mice and triangles represent Cd19-Creki/+ Dicer1fl/fl mice. Color code represents mouse age (black, < 10 weeks old; blue, 10 to
20 weeks old; and orange, > 20 weeks old). Mean values are shown as horizontal bars. See also Figure S1 and Table S1.
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MicroRNAs Prevent Autoimmunity(Koralov et al., 2008), which promotes deletion of close to 100%
of bone marrow B lineage cells (Hobeika et al., 2006) from the
pro-B cell stage (Koralov et al., 2008). Consistently,Cd19-Creki/+
Dicer1fl/fl mice showed a substantial depletion (86% reduction)
of Dicer mRNA in immature B220+IgM+ bone marrow cells but
not at earlier differentiation stages (Figure S1A available online).
Analysis of bonemarrow revealed amild reduction of total B220+
cells in Cd19-Creki/+ Dicer1fl/fl mice (Figure 1A), although
percentages of pro-B, pre-B, and immature IgM+ cells were
normal (Figures S1B and S1C and Figure 1B). In contrast, the
proportion of recirculating IgD+ cells was reduced in Cd19-
Creki/+ Dicer1fl/fl mice to 35% of control values (19.7% ±
10.0% versus 7.0% ± 4.8%) (Figure 1B), suggesting that the
reduced number of B220+ cells in Dicer-deficient bone marrow
wasmostly accounted for by a defect in the generation of mature
B cells, rather than in earlier stages. In agreement with these
results, the percentage of peripheral B cells was decreased in
spleen and lymph nodes in Cd19-Creki/+ Dicer1fl/fl mice (spleen,
50.2% ± 7.2% versus 35.0% ± 7.5%; lymph nodes, 14.7% ±
5.6% versus 6.0% ± 2.3%, Figures 1C and 1D), with absolute
spleen B cell numbers reduced to 41% of those in control
animals (Figure S1D and Table S1). Non-B cell subsets, including
T regulatory cells, were present in normal numbers and showed
normal Dicer expression in Cd19-Creki/+ Dicer1fl/fl mice (Figures
S1D–S1I), indicating that Dicer was specifically depleted in the B714 Immunity 33, 713–722, November 24, 2010 ª2010 Elsevier Inc.cell lineage in this model. No differences were observed when
Cd19-Creki/+ Dicer1fl/+ mice were compared to Cd19-Creki/+
Dicer1+/+ mice (data not shown). Therefore, Dicer depletion in
Cd19-Creki/+ Dicer1fl/fl mice is compatible with the generation
of peripheral B cells, but their number is severely reduced.
Peripheral B Cell Subsets Are Shifted in Cd19-Creki/+
Dicer1fl/fl Mice
Once in the periphery, transitional IgM+ B cells progressively
start expressing IgD and terminally differentiate into either MZ
or FO B cells (Carsetti et al., 2004; Su et al., 2004). FO or conven-
tional B cells (CD21+CD23brightCD93) populate the inner follicle
and are associated to T cell-dependent immune responses. In
contrast, MZ B cells (CD21brightCD23+) are recruited to the outer
layer of spleen follicles and provide a first and rapid response
against blood-borne antigens (Martin et al., 2001). In addition,
a third B cell subset, called B1 cells, populates the spleen and
peritoneal cavities and is believed to contribute with natural anti-
bodies to T cell-independent responses (Allman and Pillai, 2008;
Martin et al., 2001). Both MZ and B1 cells have been associated
with the generation of self-reactive antibodies (Allman and Pillai,
2008; Dammers et al., 2000; Hayakawa et al., 1984; Li et al.,
2002; Martin and Kearney, 2000). We found that in Cd19-Creki/+
Dicer1fl/fl mice the percentage of spleen transitional B cells
(CD21+CD23brightCD93+) was increased (39.8% ± 12.8% versus
Figure 2. Dicer-Deficient Cells in Mixed Chimeras
Show a Reduction in Total Peripheral B Cell Genera-
tion and an Overrepresentation of MZ and T Cell
Subsets
Phenotypic analysis of bone marrow and spleen from lethally
irradiated mice 12 weeks after bone marrow transfer with
100% CD45.2+ Cd19-Creki/+ Dicer1fl/+ or 100% CD45.2+
Cd19-Creki/+ Dicer1fl/fl cells (A) and 1:1 mixtures of bone
marrow cells from CD45.2+ Cd19-Creki/+ Dicer1fl/+ or
CD45.2+ Cd19-Creki/+ Dicer1fl/fl mice with bone marrow cells
from CD45.1+ wild-type mice (B). Representative FACS
analyses for the indicated markers are shown for B220+-gated
CD45.2+ bone marrow cells (top histograms), B220+-gated
CD45.2+ spleen cells (middle histograms) and B220+
CD23bright-gated CD45.2+ spleen cells (bottom histograms).
Numbers in the gates show the percentage mean within
CD45.2+B220+ cells of the following populations: top histo-
grams, IgD+ recirculating B cells (A: n = 3, p < 0.01; B: n = 4,
p < 0.01); middle histograms, CD21brightCD23+ marginal
zone B cells (A: n = 3, p < 0.01; B: n = 4, p = 0.03); and bottom
histograms, CD21+CD23brightCD93 follicular B cells (A: n = 3,
p < 0.01; B: n = 4, p < 0.01) and CD21+CD23brightCD93+ tran-
sitional B cells (A: n = 3, p < 0.01; B: n = 4, p < 0.01). Total
numbers, means, and standard deviations of the indicated
cell subsets in the mixed chimeras are shown in Table S2.
See also Figure S2.
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MicroRNAs Prevent Autoimmunity16 ± 7.3%), and the percentage of FO B cells (CD21+
CD23brightCD93) was decreased (24.1% ± 8.6% versus
60.4% ± 3.2%) (Figures 1E and 1F). This effect was accompa-
nied by an overrepresentation of MZ B cells (10.8% ± 4.8%
versus 20.8% ± 6.2%) (Figure 1E and Table S1) and of B1a
and B1b subsets (Figures S1J and S1K). These results suggest
that the absence of Dicer preferentially drives differentiation of
transitional B cells into MZ B cells rather than FO B cells.
Terminal Differentiation of Transitional Cells Is Altered
in Dicer-Deficient Mice
The relative contribution of different spleen B cell subsets re-
flected a severe drop in the absolute number of FO cells,
whereas transitional and MZ B cell numbers were normal or
slightly increased (Table S1). A number of mouse models with
defective B cell differentiation tend to accumulate a higher
proportion of MZ and B1 cells accompanying a severe defect
of FO cell generation (Martin and Kearney, 2002). This phenom-
enon is probably due to complex homeostatic mechanisms that
seemingly compensate a lymphopenic scenario by favoring the
generation of a competent first-barrier defense provided by B1
andMZ cells (reviewed inMartin and Kearney, 2002). To discrim-
inate whether the MZ versus FO bias observed in Dicer-deficient
animals was due to lymphopenia-driven compensatory events or
to a true requirement of microRNAs for FO B cell differentiation
from transitional cells, we performed reconstitution experiments
by using bone marrow mixed chimeras. We mixed wild-type
CD45.1+ bone marrow cells with CD45.2+ cells from either
Cd19-Creki/+ Dicer1fl/+ (50% Dicer1fl/+) or Cd19-Creki/+ Dicer1fl/fl
(50% Dicer1fl/fl) mice. Unmixed bone marrow cells from CD45.2+
Cd19-Creki/+ Dicer1fl/+ (100% Dicer1fl/+) and Cd19-Creki/+IDicer1fl/fl (100% Dicer1fl/fl) mice were used as controls. Cells
were transferred into lethally irradiated CD45.2+ wild-type hosts,
and bone marrow and spleen reconstitution was assessed after
12 weeks. At this time point, the number of CD45.2+ B220+ cells
was <1% of normal numbers in mice that were transferred with
CD45.1 cells alone, indicating that the contribution of host-
derived B cell progenitors is negligible in these experiments
(data not shown). As expected, we found that 100% Dicer1fl/fl
reconstitution resulted in a decrease of both IgD+ bone marrow
and FO spleen subsets as compared to 100%Dicer1fl/+ reconsti-
tuted mice, phenocopying our observations in Cd19-Creki/+
Dicer1fl/+ and Cd19-Creki/+ Dicer1fl/fl animals (Figure 2A).
CD45.1+ wild-type cells alleviated the lymphopenia driven by
Dicer-deficient cells, given that 50% Dicer1fl/fl mixed chimeras
contained total absolute numbers of transitional, FO, and MZ
cells indistinguishable from those in 50% Dicer1fl/+ control
chimeras (Table S2). In spite of the normal numbers of total
spleen cells, we observed that CD45.2+ cells in 50% Dicer1fl/fl
reconstituted mice still showed an impairment of FO B cell
generation (60.6% ± 3.5% versus 34.9% ± 2.6%) and an over-
representation of the MZ compartment (8.7% ± 1.5% versus
13.8% ± 2.7%) (Figure 2B and Table S2). These results indicate
that MZ overrepresentation in Dicer-deficient animals is not
a homeostatic response secondary to lymphopenia, but instead
reflects a skewed terminal differentiation pattern promoted by
the absence of microRNAs. To rule out that this phenotype could
be the result of an enhanced depletion of microRNAs taking
place specifically in FO cells, we measured Dicer expression in
transitional, MZ, and FO cells from Cd19-Creki/+ Dicer1fl/+ and
Cd19-Creki/+Dicer1fl/fl spleens (Figure S2). This analysis showed
that Dicer expression was lowest at the transitional stage ofmmunity 33, 713–722, November 24, 2010 ª2010 Elsevier Inc. 715
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MicroRNAs Prevent AutoimmunityCd19-Creki/+ Dicer1fl/fl spleens and that it slightly increased in
mature FO cells. This result indicates that Dicer depletion does
not proceed beyond the transitional stage and rather suggests
that those cells retaining some Dicer expression selectively
differentiate into FO cells. We conclude that Dicer depletion in
late B cell differentiation results in a biased terminal differentia-
tion of transitional cells that impairs FO cell development while
favoring the generation of MZ cells.
MicroRNA Profiling in FO and MZ B Cells
To examine the microRNAs that could be functionally relevant in
determining the FO versus MZ B cell fate, we performed micro-
array analysis and compared microRNA expression in FO and
MZ B cells from Cd19-Creki/+ Dicer1fl/+ mice. FO and MZ B cells
were isolated by cell sorting, and RNA was labeled and hybrid-
ized to microRNA arrays. We consistently detected expression
of 177 microRNAs in FO cell samples. Statistical analysis was
performed so that those microRNAs that were differentially
expressed in MZ versus FO B cells could be identified (p < 0.1,
see Experimental Procedures). This analysis showed that 31 of
the 177 detected microRNAs were differentially expressed in
these two subsets (Figure 3A), all of which were found to be
expressed at lower amounts in FO Cd19-Creki/+ Dicer1fl/fl than
in FO Cd19-Creki/+ Dicer1fl/+ cells (not shown), as expected
from the absence of Dicer. Interestingly, we found that in
Cd19-Creki/+ Dicer1fl/+ control animals all 31 microRNAs were
expressed at higher amounts in FO than inMZB cells (Figure 3A).
This result was validated by real-time RT-PCR for a number of
microRNAs, including miR141, miR16, miR192, and miR194. In
all the cases, we found that RT-PCR results confirmed that these
microRNAs displayed higher expression in FO than in MZ B cells
(Figure S3A). This observation accords with our finding that in
Cd19-Creki/+ Dicer1fl/fl mice MZ generation is favored over FO
generation and suggests that microRNAs can be more determi-
nant for FO than MZ B cell differentiation.
miR185 and Btk Deregulation in Cd19-Creki/+ Dicer1fl/fl
B Cells Shifts BCR Stimulation Response
To gain insights into the functional relevance of the differentially
expressed microRNAs identified by array analysis, we followed
a hypothesis-driven bioinformatics approach by searching for
microRNAs that could target genes reported to play a role in
the FO versus MZ B cell generation. In particular, we performed
a prediction search using three independent software (MiRanda,
miRBase, and TargetScan) by scanning all differentially
expressed microRNAs for potential binding to Aiolos (gene
symbol, Ikzf3), Btk, CD21 (gene symbol, Cr2), and Notch2
mRNAs. We found that all three software predicted miR185 to
target one such gene, Btk (Figure S3B), with an identical seed
sequence at position 17–39 of its 30 UTR. Btk, a kinase that trans-
duces signals downstream of the BCR, has been shown to be
involved in the generation or recruitment of autoreactive B cells
to the MZ area (Martin and Kearney, 2000). Real-time PCR
analysis confirmed that miR185 expression was regulated in
peripheral B cell subsets, with transitional cells displaying inter-
mediate miR185 amounts that were upregulated in FO cells and
downregulated in MZ cells (Figure S3C).To test whether miR185
can be regulating Btk expression in B cells, we overexpressed
miR185 in primary B cells from wild-type spleens and measured716 Immunity 33, 713–722, November 24, 2010 ª2010 Elsevier Inc.Btk expression by real-time PCR after 3 days of LPS + IL4 stim-
ulation.We found thatmiR185 transduction, but not transduction
of mock or an irrelevant miRNA (miR27a) vector, resulted in
a decrease of Btk mRNA expression (Figure 3B, p = 0.005). Dicer
expression itself, included as a control, was unchanged in B cells
transducedwith any of the three vectors (Figure 3B). Importantly,
we found that Btk protein expression was increased in Cd19-
Creki/+ Dicer1fl/fl spleen B cells when compared to Cd19-Creki/+
Dicer1fl/+ counterparts (Figure 3C). Specifically, Btk expression
was substantially increased in transitional and FO Cd19-Creki/+
Dicer1fl/fl cells, whereas this difference is not evident in MZ cells,
in agreement with the observed block in FO but not MZ B cell
differentiation (Figure 3D). The strength of BCR signaling is crit-
ical for determining B cell fate (Grimaldi et al., 2005; Pillai and
Cariappa, 2009; Shlomchik, 2008), and Btk has been reported
as one of the components involved in establishing this threshold
and influencing the differentiation of MZ B cells (Halcomb et al.,
2008; Khan et al., 1995; Martin and Kearney, 2000; Ng et al.,
2004; Satterthwaite et al., 1997). To determine whether elevated
Btk expression correlated with enhanced BCR signaling in
Cd19-Creki/+ Dicer1fl/fl B cells, we examined the increase of
ERK phosphorylation in Cd19-Creki/+ Dicer1fl/+ and Cd19-Creki/+
Dicer1fl/fl B cells in response to BCR stimulation. We found that
stimulation with IgM antibodies consistently resulted in a higher
amount of ERK phosphorylation in Dicer-deficient B cells when
compared to control cells (Figure 3E). We next addressed down-
stream events of BCR signaling by analyzing the efficiency of
class switch recombination in B cells stimulated with anti-IgM
and IL4. Consistent with the observed increase in Btk protein
expression and ERK phosphorylation, Cd19-Creki/+ Dicer1fl/fl B
cells showed a higher rate of class switch recombination to
IgG1 (1.5% ± 0.25% versus 3.2% ± 0.78% at 72 hr, p = 0.03)
(Figure 3F). To address whether deregulated expression of
miR185 and Btk was directly responsible for the enhanced
BCR signaling phenotype, we performed gain-of-function exper-
iments. Spleen B cells from wild-type mice were BCR stimulated
with anti-IgM and IL-4, transduced with retroviruses encoding
either Btk or miR185 precursor, and measured the rate of class
switch recombination to IgG1.We found that Btk overexpression
recapitulated the phenotype observed in Cd19-Creki/+ Dicer1fl/fl
B cells, i.e., increased the rate of class switch recombination
(control, 5.3% ± 1.6%; Btk-transduced, 7.7% ± 2.1%).
Conversely, miR185 overexpression resulted in a decrease of
the class switch recombination efficiency (control, 5.3% ±
1.6%; miR185-transduced, 4.0% ± 1.8%) (Figure 3G). Together,
these results establish a direct role of miR185 downregulation in
the modulation of BCR signaling inCd19-Creki/+Dicer1fl/fl B cells
through the release of negative regulation of Btk and suggest
that altered BCR signaling is responsible for the biased selection
and commitment of Cd19-Creki/+ Dicer1fl/fl peripheral B cells.
Cd19-Creki/+ Dicer1fl/fl B Cells Express
a Skewed Ig Repertoire
To determinewhether the altered pattern of B cell generation and
BCR signaling results in a skewed selection of the antibody
repertoire in the absence of microRNAs, we examined the VDJ
rearrangements of the expressed immunoglobulin heavy chains
in B cells from Cd19-Creki/+ Dicer1fl/+ and Cd19-Creki/+ Dicer1fl/fl
mice. Spleen B cells were isolated and the proportion of
Figure 3. MicroRNA Analysis of FO and MZ B Cells and BCR Signaling Alterations in Dicer-Deficient Cells
(A) MicroRNA profiling of FO andMZ cell subsets of Cd19-Creki/+Dicer1fl/+ mice. CD21+CD23bright follicular (FO) and CD21brightCD23+ marginal zone (MZ) B cells
were separated by cell sorting from Cd19-Creki/+ Dicer1fl/+ spleens. RNA was isolated, labeled, and hybridized on Agilent microRNA arrays. Differentially ex-
pressed microRNAs in MZ (gray bars) versus FO (black bars) cells (see Experimental Procedures) are shown (p < 0.1). Bars represent fluorescence intensity
normalized to FO cells (mean values of three independent experiments).
(B) Differentially expressed microRNAs (shown in A) were subjected to target prediction analysis of genes potentially involved in MZ versus FO cell differentiation
and/or maintenance. miR185 was predicted to target Btk by all three miRNA target prediction software used (MiRanda, TargetScan, and miRBase). Control,
miR185, and miR27a (not predicted to target Btk) retroviral vectors were transduced into primary B cells from wild-type spleens in the presence of LPS and
IL4. Two days after transduction, RNA was isolated and Btk mRNA was measured by real-time RT-PCR (control versus miR185: n = 4, p < 0.01). Dicer
mRNA amounts from the same samples are shown as a negative control (control versus miR185: n = 4, p = 0.73). Bars represent mRNA amounts after normal-
ization to GAPDH expression and relative to control-transduced cells. Standard deviations are shown.
(C) Btk protein expression is increased in spleen B cells of Dicer-deficient mice. Two-fold serial dilutions of total lysates from Cd19-Creki/+ Dicer1fl/+ and Cd19-
Creki/+Dicer1fl/fl spleen B cells were analyzed by immunoblotting with Btk and tubulin antibodies. Densitometric quantification is shown on the right; the black bar
represents Cd19-Creki/+ Dicer1fl/+ mice and the white bar represents Cd19-Creki/+ Dicer1fl/fl mice (n = 2, p < 0.01).
(D) Btk protein expression in B cell subsets. Spleen cell suspensions from Cd19-Creki/+ Dicer1fl/+ (black bars) and Cd19-Creki/+ Dicer1fl/fl mice (white bars) were
surface stained with anti-B220, anti-CD21, anti-CD23, and anti-CD93, intracellularly stained with anti-Btk, and analyzed by flow cytometry. Mean fluorescence
in the indicated subsets was normalized to Cd19-Creki/+ Dicer1fl/+ cell fluorescence in total B220+ cells (B220+: n = 8–10, p < 0.01; T: n = 8–10, p = 0.02; MZ:
n = 8–10, p = 0.41; FO: n = 8–10, p < 0.01).
(E) Increased phospho-ERK expression inCd19-Creki/+Dicer1fl/fl cells.Cd19-Creki/+Dicer1fl/+ andCd19-Creki/+Dicer1fl/fl spleen B cells were stimulated with anti-
IgM and total lysate from 13 106 cells was loaded per lane for analyzing anti-phospho-ERK and anti-ERK protein expression by immunoblotting. Time after stim-
ulation is indicated over each lane.
(F) Increased class switching in Dicer-deficient cells upon stimulation with anti-IgM. Spleen B cells from Cd19-Creki/+ Dicer1fl/+ (filled circles) and Cd19-Creki/+
Dicer1fl/fl mice (triangles) were isolated and cultured in the presence of anti-IgM and IL4. The efficiency of class switch recombination to IgG1 was analyzed by
flow cytometry at the indicated time points (n = 3).
(G) Btk and miR185 gain-of-function analysis. Wild-type spleen B cells were transduced with Btk, miR185, or empty vectors in the presence of anti-IgM and IL4.
The efficiency of class switching to IgG1 was analyzed by flow cytometry 96 hr after transduction. Bars represent the percentage of IgG1+ cells within transduced
GFP+ cells. Standard deviations from three independent experiments are shown (n = 3, p = 0.03). See also Figure S3.
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MicroRNAs Prevent AutoimmunityJH elements was determined after RT-PCR, cloning, sequencing
and IgBlast analysis (Table S3 and Figure 4A). We found that the
usage of JH genes was significantly altered (p = 0.0002) in Cd19-
Creki/+Dicer1fl/fl as compared to control B cells, with an overrep-Iresentation of JH4 segments in Dicer-deficient cells (Figure 4A).
In addition, the number of R and K residues at the CDR3 region,
a feature of autoreactivity (Crouzier et al., 1995; Ichiyoshi
and Casali, 1994; Wardemann et al., 2003), was significantlymmunity 33, 713–722, November 24, 2010 ª2010 Elsevier Inc. 717
Figure 4. Cd19-Creki/+Dicer1fl/fl B Cells Express a Skewed Ig Reper-
toire
Analysis of the expressed IgH repertoire in control and Dicer-deficient B cells.
B cells were isolated from Cd19-Creki/+ Dicer1fl/+ and Cd19-Creki/+ Dicer1fl/fl
spleens by immunomagnetic depletion. RNA was extracted, retrotranscribed,
and PCR-amplified with oligonuclotides specific for VHJ558 or VH7183 in
combination with a Cm oligonucleotide. PCR products were cloned,
sequenced, and analyzed with IgBlast software. Sectors represent the contri-
bution of JH segments (A) (n = 74-75, p < 0.01) and of sequences containing 0,
1, or R 2 R+K residues at CDR3 (B) (n = 74–75, p = 0.03) for Cd19-Creki/+
Dicer1fl/+ and Cd19-Creki/+ Dicer1fl/fl B cells. Results were pooled from four
independent animals of each genotype. Complete sequence analysis is shown
in Table S3.
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MicroRNAs Prevent Autoimmunityincreased (p = 0.03) in Cd19-Creki/+ Dicer1fl/fl B cells (Figure 4B).
Therefore, in the absence of Dicer there is a redistribution of vari-
able segments in the antibody repertoire.Cd19-Creki/+ Dicer1fl/fl Females Display Autoimmune
Features
The observation that microRNA-deficient B cells contain a higher
number of positive charges in their Ig heavy chains prompted us
to assess the autoreactivity of serum Igs from Cd19-Creki/+
Dicer1fl/+ andCd19-Creki/+Dicer1fl/fl mice. Sera fromCd19-Creki/+
Dicer1fl/+ and Cd19-Creki/+ Dicer1fl/fl animals were collected andFigure 5. Cd19-Creki/+ Dicer1fl/fl Mice Have High Serum Titers of Autor
Analysis of serum Ig titers against self-antigens. Serum from 40- to 60-week-oldC
collected and reactivity against dsDNA (A), ssDNA (B), and cardiolipin (C) was asse
ground signal from RAG knockout mouse serum was subtracted and values we
results obtained from males (gray) and females (black) are represented separate
two standard deviations to the mean value of the titers detected in the control Cd
test) between the indicated groups are shown (n = 9–17). See also Figure S4.
718 Immunity 33, 713–722, November 24, 2010 ª2010 Elsevier Inc.antibody reactivity against self-antigenswasmeasured by ELISA
and compared to titers found in MRLlpr/lpr mice. Importantly, we
found that titers of IgGs against dsDNA, ssDNA, and cardiolipin
autoantigens were significantly increased in serum from aged
female but not male Cd19-Creki/+ Dicer1fl/fl mice (Figures 5A–
5C). Although total IgG and IgM antibody titers were on average
slightly increased inCd19-Creki/+Dicer1fl/fl mice (not shown), this
difference was not statistically significant and did not correlate
with the autoantibody titers in individual mice (Figure S4). This
suggests that accumulation of autoantibodies in the absence
of Dicer is not passively correlated to higher total Ig titers, but
rather is the result of a biased repertoire selection. To address
the pathogenicity of autoantibodies in Dicer-deficient females,
we assessed the presence of immune complexes in kidney
sections. Indeed, immunoflurescence analysis revealed a prom-
inent accumulation of IgG inCd19-Creki/+Dicer1fl/fl aged females
when compared to control animals (Figure 6A and Figure S5A),
indicative of deposition of immune complexes. Moreover,
silver-PAS staining of kidney sections showed massive lympho-
cyte infiltration and overall damage of glomerulus architecture
that affected 50% of aged Dicer-deficient females (Figure 6B
and Figure S5B). We conclude that the absence of microRNAs
gives rise to a skewed antibody repertoire enriched in self-reac-
tive specificities that leads to the development of autoimmune
disease.
DISCUSSION
In this study, we have addressed the role of microRNAs in
terminal B cell differentiation by analyzing Cd19-Creki/+ Dicer1fl/fl
mice. Although CD19 expression and Dicer deletion could be
expected to take place at the pre-B stage of bonemarrow devel-
opment (Rickert et al., 1997), we found that the expression of
Dicer mRNA is substantially decreased only in bone marrow
IgM+ cells. This late depletion, which probably reflects a gradual
deletion during bonemarrow differentiation (Hobeika et al., 2006)
together with a high stability of Dicer mRNA, allowed the gener-
ation of mature B cells and their migration to peripheral tissues.
Indeed, the sharpest reduction in Dicer expression was
observed in spleen transitional cells. We found here that in the
absence of Dicer, normal numbers of transitional B cells areeactive Antibodies
d19-Creki/+Dicer1fl/+ (circles) andCd19-Creki/+Dicer1fl/fl (triangles) animals was
ssed by ELISA. The results are represented as relative colorimetric units. Back-
re normalized to the signal obtained from MRLlpr/lpr mouse serum. For clarity,
ly. A threshold for autoreactive antibody titers was established by addition of
19-Creki/+ Dicer1fl/+ mice (shown as a gray dotted line). p values (Fisher’s exact
Figure 6. Cd19-Creki/+ Dicer1fl/fl Females Display Autoimmune
Features
(A) Immunocomplexes in kidneys from Dicer-deficient females. Kidney
sections from 40- to 60-week-old Cd19-Creki/+ Dicer1fl/+ and Cd19-Creki/+
Dicer1fl/fl animals were stained with anti-IgG. Representative immunofluores-
cence glomerular stainings are shown at two different magnifications. Scale
bars are indicated.
(B) Kidney damage in Cd19-Creki/+ Dicer1fl/fl mice. Formalin-fixed kidney
sections from Cd19-Creki/+ Dicer1fl/+ and Cd19-Creki/+ Dicer1fl/fl aged mice
were subjected to Silver-PAS staining. Scale bars are shown. See also Fig-
ure S5.
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MicroRNAs Prevent Autoimmunitygenerated, which can differentiate normally into MZ B cells; in
contrast, the generation of FO B cells is severely compromised.
Interestingly, this biased differentiation is cell autonomous,
which indicates that microRNAs are critical for MZ versus FO
cell fate determination. In this regard, we provide in this study
the first analysis of microRNA expression in MZ versus FO B
cells. Notably, we found that only a relatively reduced number
of microRNAs are differentially expressed in MZ versus FO cells,
all of which display a higher expression amount in the latter pop-
ulation. This global overexpression of microRNAs in the FO
subset could in turn be related to the higher Dicer expression
found in FO cells as compared with transitional or MZ B cells.
Differential Dicer expression in theseBcell subsets is a somehow
unexpected result that deserves further investigation. Regard-
less of the regulatory mechanism responsible for this expression
pattern, this microRNA profiling can open new perspectives on
the study of the developmental program that determines the
selective mechanisms operating at transitional B cells and their
final commitment into MZ and FO subsets.
A number of findings presented here support the idea that FO
B cell generation has a deeper dependency on microRNA
expression: (1) Dicer-deficient B cell progenitors give rise to
normal numbers of transitional and MZ cells but to severely
reduced numbers of FO cells, as measured in Cd19-Creki/+
Dicer1fl/fl animals, bone marrow transfers and competitive
bone marrow chimeras; (2) in wild-type animals, differentially ex-
pressed microRNAs show higher expression in FO than in MZ;
and (3) the few FO cells that are generated in Cd19-Creki/+
Dicer1fl/fl mice express higher amounts of Dicer than their imme-
diate precursors, transitional cells, suggesting that only cells
where Dicer depletion is incomplete—i.e., deletion of a single
allele—selectively differentiate into the FO cell lineage.
Btk is known to influence the MZ versus FO cell lineage deci-
sion, and we report here that miR185 negatively regulates the
expression of Btk in primary B cells. We show that miR185
expression is regulated during terminal B cell differentiation,Iwith intermediate amounts at the transitional stage that become
downregulated in MZ B cells and upregulated in FO cells. Impor-
tantly, this expression pattern mirrors that of Btk expression,
which suggests that greater Btk amounts are more compatible
with the generation of MZ B cells and suggests a link between
the skewed generation of MZ and FO cells observed in Dicer-
deficient animals and an altered BCR signaling. We show that
this is indeed the case. Dicer-deficient B cells contain higher
amounts of Btk protein and ERK phosphorylation and they
undergo class switch recombination in response to BCR stimu-
lation at a higher rate than control animals. This effect is
phenocopied by Btk overexpression and counterbalanced by
miR185 overexpression. Therefore, although other molecular
pathways can play a role in the observed phenotype in Cd19-
Creki/+ Dicer1fl/fl mice, our data provide evidence that miR185
and Btk contribute to determining B cell fate by influencing the
outcome of BCR signaling.
This notion is further reinforced by the finding that the Ig
repertoire expressed by peripheral B cells is skewed in these
animals. This observation could be explained by a shifted usage
of JH segments during V(D)J recombination or by an abnormal
selection of the Ig repertoire. However, given that major Dicer
mRNA depletion is first observed in immature IgM+ cells, the
first possibility is very unlikely and our results rather support
the view that in Dicer-deficient B cells, the establishment of
tolerance is incomplete. Our data suggest that Dicer deficiency
results in lower amounts of miR185 and accumulation of Btk,
which in turn can allow the selection of B cells bearing self-reac-
tive BCRs and favor the final commitment of some of these cells
into a MZ fate. This hypothesis is compatible with the observa-
tion that relatively subtle changes in Btk expression and/or
activity influence the generation of MZ and FO cells (Dingjan
et al., 1998; Maas et al., 1999) and could explain the observed
accumulation of serum autoantibodies and the presence of
features of autoimmune disease in aged Dicer-deficient
animals.
Interestingly, the autoimmune disease observed in Dicer-defi-
cient animals was predominantly found in female rather than
male mice, very much resembling the profound prevalence of
female incidence in various autoimmune diseases in humans,
such as systemic lupus erythematosus, Sjoegren’s syndrome,
or scleroderma (Whitacre, 2001). Therefore, we envision that
the analysis of microRNA expression profiles can prove clinically
useful in the diagnosis and prognosis of autoimmune disease. In
summary, our data provide evidence on the role of microRNAs in
maintaining a tolerant antibody repertoire and will contribute
a new perspective on gender-biased autoimmune syndromes
by allowing the study of microRNA-based gene regulation under
differential hormone contexts.EXPERIMENTAL PROCEDURES
Mice
B cell-specific Dicer-deficient (Cd19-Creki/+ Dicer1fl/fl) and littermate control
(Cd19-Creki/+ Dicer1fl/+) mice were generated by breeding Dicer1fl/fl to Cd19-
Creki/+ (Harfe et al., 2005; Rickert et al., 1997) mice. All mice were housed
under pathogen-free conditions in accordance with the recommendations of
the Federation of European Laboratory Animal Science Associations. All
experiments were performed following the Animal Bioethics and Comfort
Committee protocols approved by the Instituto de Salud Carlos III.mmunity 33, 713–722, November 24, 2010 ª2010 Elsevier Inc. 719
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Cells from bone marrow and spleen were collected and erythrocytes were
lysed with ACK Lysing Buffer (BioWhittaker). Then, cells were cell surface-
stained with different combinations of anti-mouse Btk, IgM, IgD, IgG1,
Mac-1, CD3, CD4, CD5, CD21, CD23, CD25, CD43, and CD45.2 (BD Biosci-
ences) and anti-B220 (Miltenyi Biotec) and anti-CD93 (eBioscience). For Btk
intracellular staining, extracellular marked cells were fixed with PFA and per-
meabilized with 0.05% saponin and stained with Btk antibody in 13 PBS-
0.05% saponin. Flow cytometry analyses were performed in a FACSCanto
flow cytometer with FACSDiva (BD Biosciences) or FlowJo (Tree Star)
softwares.
Bone Marrow Reconstitution
A total of 5 3 106 total bone marrow cells from CD45.1 C57BL/6, CD45.2
Cd19-Creki/+ Dicer1fl/+, or CD45.2 Cd19-Creki/+ Dicer1fl/fl donor mice were in-
jected intravenously into 8- to 12-week-old CD45.2 C57BL/6 mice that had
been lethally irradiated (2 3 550 cGy) 24 hr before the reconstitution. For
competitive bone marrow reconstitutions, mice were injected with cell
mixtures containing 2.5 3 106 bone marrow cells from CD45.1 C57BL/6
mice and 2.5 3 106 bone marrow cells from CD45.2 Cd19-Creki/+ Dicer1fl/+
or Cd19-Creki/+ Dicer1fl/fl mice. Chimeric mice were analyzed 12 weeks after
the reconstitution.
Cell Cultures
293T cells were cultured in DMEM supplemented with 10% FCS. Primary
spleen B cells were purified from spleens by immunomagnetic depletion
with anti-CD43 beads (Miltenyi Biotec) and cultured in RPMI 1640 supple-
mented with 10% FCS, 10 mM HEPES (Invitrogen), and 50 mM b-mercaptoe-
thanol (Invitrogen). For Btk expression analysis upon miRNA overexpression,
25 mg/mL LPS (Sigma-Aldrich) and 10 ng/mL IL4 (PeproTech) were added to
the medium. For class switch recombination analysis, 10 mg/mL F(ab)’2 frag-
ments of goat anti-mouse IgM (Jackson Immunoresearch) and 10 ng/mL IL4
(PeproTech) were added to the medium.
Retroviral Infection
Retroviral supernatants were produced by transient calcium phosphate
cotransfection of NIH-293T cells with pCL-Eco (Imgenex) and pre-miRNA-
GFP retroviral vectors or pMXPIE-Btk retroviral vector. pre-miRNA-GFP
vectors encoded pre-miRNA (pre-miR27a or pre-miR185) and their flanking
50-bp-long genomic sequences (de Ye´benes et al., 2008). Mouse primary B
cells were transduced with retroviral supernatants for 20 hr in the presence
of 8 mg/ml polybrene (Sigma), 10 mM HEPES (Invitrogen), and 50 mM b-mer-
captoethanol (Invitrogen). For Btk expression analysis upon miRNA overex-
pression, 25 mg/ml LPS (Sigma) and 10 ng/ml IL-4 (Peprotech) were added
to the retroviral supernatants. GFP-positive cells were sorted 48 hr after trans-
duction (FACSAria, BD Biosciences). For class switch recombination analysis
upon Btk or miR185 overexpression, 10 mg/mL F(ab)’2 fragments of goat anti-
mouse IgM (Jackson Immunoreserach) and 10 ng/mL IL4 (PeproTech) were
added to the retroviral supernatant. Ninety-six hours after transduction, IgG1
expression in GFP-positive cells was determined by flow cytometry.
miRNA Microarrays
Spleen cells fromCd19-Creki/+Dicer1fl/+ andCd19-Creki/+Dicer1fl/fl mice were
stained with anti-B220, anti-CD21, and anti-CD23 as described above. B220+
CD21brightCD23+ (marginal zone) and B220+CD21+CD23bright (follicular) B cell
populations were sorted (FACSAria, BD Biosciences) and total RNA of purified
populations was extracted with TRIzol (Invitrogen) in accordance with the
manufacturer’s instructions. miRNA microarray hybridations were performed
on mouse miRNA Microarray platform (Agilent Technologies). Local back-
ground was subtracted from median signal and intensity was transformed to
a log2 scale. Normalized data were analyzed withMultiExperiment Viewer soft-
ware. First, paired t test was used for determining differentially expressed
miRNAs in MZ versus FO control (Cd19-Creki/+ Dicer1fl/+) cells. miRNAs with
a p value % 0.1 and fold-expression differenceR2 were selected for further
analysis. Then control (Cd19-Creki/+ Dicer1fl/+) and Dicer-deficient (Cd19-
Creki/+ Dicer1fl/fl) cells were compared with an unpaired t test for both MZ
and FO cell subsets. Again, miRNAs with a p value% 0.1 and fold-expression
differenceR 2were selected. Thirty-onemiRNAswere identified in FO-control720 Immunity 33, 713–722, November 24, 2010 ª2010 Elsevier Inc.versus Dicer-deficient analysis and only four were identified in MZ-control
versus Dicer-deficient analysis, all of which were contained in the FO analysis
results.
Real-Time PCR
B cell populations were sorted from spleen or bone marrow after staining with
B220, IgM, CD21, CD23, and CD93 antibodies. T regulatory cells were isolated
(>90%purity) with the CD4+CD25+ Regulatory T Cell Isolation Kit (Miltenyi Bio-
tec). Total RNA was extracted with TRIzol (Invitrogen) and converted into
cDNA with random hexamers (Roche) and SuperScript II reverse transcriptase
(Invitrogen). Mouse Dicer and Btk mRNA were quantified with SYBR green
assay (Applied Biosystems). GAPDH amplifications were used as normaliza-
tion controls. The following primers were used: Dicer (forward): 50 -ACGAAA
TGCAAGGAATGGACTC-30; Dicer (reverse): 50-GGCACCAGCAAGAGACTC
AAA-30; Btk (forward): 50-AGCGCTCCCAGCAGAAAAA-30; Btk (reverse): 50-CT
TACTGCCTCTTCTCCCACG-30; GAPDH (forward): 50-TGAAGCAGGCATCTGA
GGG-30; GAPDH (reverse): 50-CGAAGGTGGAAGAGTGGGAG-30. For mature
miRNA expression analysis, total RNA was extracted as previously described.
Retrotranscription and real-time PCRwere performedwith TaqManMicroRNA
Assays (Applied Biosystems) in accordance with recommendations of the
manufacturer. Amplification of sno142 was used as a normalization control.
Immunoblotting
Spleen B cells from Cd19-Creki/+ Dicer1fl/+ and Cd19-Creki/+ Dicer1fl/fl mice
were purified by immunomagnetic depletion as described above. For Btk
immunoblotting, cell pellets were incubated on ice for 20 min in lysis buffer
containing 20 mM Tris, 150 mM NaCl, 1% Nonidet P-40 in the presence of
protease inhibitors (Roche) and lysates were cleared by centrifugation. For
phospho-ERK and ERK immunoblotting, cells were incubated for 1 hr at
37C in starvation buffer (RPMI 1640, 10mMHEPES, and 50 mM b-mercaptoe-
thanol) prior to stimulation with 10 mg/mL F(ab)’2 fragments of goat anti-mouse
IgM (Jackson Immunoreserach). Cells were pelleted after the indicated times
and lysed on ice for 30 min in lysis buffer containing 50 mM Tris-HCl
(pH 7.4), 1% Nonidet P-40, 137.5 mM NaCl, and 1% glycerol in the presence
of protease inhibitors (Roche) and phosphatase inhibitors (NaV and NaF).
Lysates were cleared by centrifugation at 4C for 15 min at 16000 3 g and
5% b-mercaptoethanol was added.
Total protein was sized-fractioned by SDS-PAGE on 10% acrylamide-bisa-
crylamide gel and transferred to Protran nitrocellulose membrane (Whatman)
in transfer buffer (0.19M glycine, 25mMTris base, and 0.01%SDS) containing
20%methanol. Gels were transferred for 1 hr at 0.4A for Btk and 2 hr at 0.2A for
phospho-ERK/ERK immunoblot. Membranes were probed with anti-mouse-
Btk (Abcam) and anti-mouse-Tubulin (Sigma-Aldrich) and anti-mouse-phos-
pho-ERK (Cell Signaling) and anti-mouse-ERK (Biosource), respectively.
Then, membranes were incubated with corresponding secondary HRP-conju-
gated antibodies (Dako) and developed with SuperSignal West Dura Extended
Duration Substrate (Thermo Scientific).
Amplification and Analysis of V(D)J Rearrangements
Spleen B cells from Cd19-Creki/+ Dicer1fl/+ and Cd19-Creki/+ Dicer1fl/fl mice
were purified and total RNA was extracted and converted into cDNA as
described above. IgH rearrangments were amplified from RT-PCR products
with 2.5 U of Taq DNA polymerase (Roche) and combining a 30 primer for Cm
exon 1 with a 50 primer for VH7183 or VHJ558. Amplification consisted of 30
cycles (30’’ at 94C, 30’’ at 57C, and 60’’ at 72C) followed by a 10 min incu-
bation at 72C. PCR products were cloned into the pGEM-T Easy vector
(Promega). Clones were selected randomly and sequenced with T7 universal
primer. Sequences were analyzed with the NCBI IgBlast program (http://
www.ncbi.nlm.nih.gov/igblast/). Cm: 50-ATTTGGGAAGGACTGACTCT-30;
VH7183: 5
0-GAGTCTGGGGGAGCTTA-30; VHJ558: 50- RGCCTGGGRCTTC
AGTGAAG-30 (R = A or G).
ELISA
Quantification of IgG and IgM autoantibodies recognizing DNA and cardiolipin
was performed by ELISA. For DNA antibodies quantification, MaxiSorp Im-
muno plates (Nunc) were incubated with 50 mg/mL poly-L-lysine (Sigma-Al-
drich) for 2 hr at 37C, then rinsed with water and coated with 100 ml of
2 mg/mL calf thymus DNA (Sigma-Aldrich) in phosphate-buffered saline
Immunity
MicroRNAs Prevent Autoimmunity(13 PBS, 0.14 M NaCl, and 0.01 M NaH2PO4) at 4
C overnight. Single-
stranded DNA was obtained by boiling DNA for 10 min and snap-chilling on
ice. For cardiolipin antibody detection, plates were coated with 100 ml of
20 mg/mL cardiolipin in ethanol at 4C overnight. Coated plates were blocked
with 4% BSA PBS for 90 min at RT and washed with 0.05% Tween 20 in PBS.
Sera were diluted in 1% BSA PBS, 1:500 for IgG DNA antibodies and 1:100 for
IgM DNA and IgG cardiolipin antibodies detection. Fifty microliters of the dilu-
tions were applied and incubated for 2 hr at RT. Plates were washed again and
autoantibodies were detected with anti-mouse-k/l-chains-POD conjugates
(Mouse IgG ELISA Kit, Roche) or goat anti-mouse IgM HRP-conjugated anti-
body (Bethyl laboratories) and then with SuperSignal ELISA Femto Maximum
Sensitivity Substrate (Thermo Scientific). The OD425nm was determined with
a conventional microplate reader. Serum from MRLlpr/lpr and RAG2 knockout
mice were used as positive and negative controls, respectively. The relative
binding capacity to DNA or cardiolipin was calculated by subtracting back-
ground signal from RAG2 knockout serum and normalizing to MRLlpr/lpr signal.
For determination of serum total Ig titers, Mouse IgG ELISA Kit (Roche) and
Mouse IgM ELISA Quantitation Kit (Bethyl laboratoires) were used in accor-
dance with the manufacturer’s instructions.
Immunofluorescence
Kidneys were embedded on OCT compound (Tissue Tek, Sakura) and snap-
frozen on dry ice. Ten micrometer sections were cut and fixed in chilled
acetone for 10 min. Sections were washed with PBS, blocked for 30 min
with blocking buffer (PBS, 1% BSA, 0.3% Triton, 0.5% goat serum, 0.5%
donkey serum, and 1% gelatin), stained with Alexa Fluor 488 donkey anti-
mouse IgG (Invitrogen), and analyzed in a Leica TCS-SP5 (AOBS) confocal
microscope with a 203 HC PL APO 0.7 N.A. oil immersion objective with
LAS AF software. The background was subtracted from mean fluorescence
intensity of each glomerulus and obtained values were normalized for control
of the mean.
Histopathology
Kidneys were fixed in 10% buffered formalin and embedded in paraffin.
Sections were stained with silver methenamine P.A.S.M. in accordance with
standard protocols.
Statistical Analysis
Bone marrow, spleen, and lymph nodes phenotypes, relative Dicer and Btk
mRNA and protein expression, and glomerulus fluorescence intensities were
analyzed with Student’s t tests. Sequence analyses were performed with
two-tailed Chi-square tests. For autoantibody ELISAs, a threshold was estab-
lished for each particular antigen (mean of Cd19-Creki/+ Dicer1fl/+ mice serum
signals plus two standard deviations). Sera with signals above this threshold
were considered autoreactive and Fisher’s exact test was performed. For renal
damage measurement, the number of affected glomeruli was analyzed with
Fisher’s exact test. Statistical analyses were carried out with GraphPad soft-
ware. The level of statistical significance was preset at p < 0.05.
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